Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Pathways in cancer	7/531	1.351016085810765E-5	0.0018644021984188556	0	0	10.823393765903308	121.35263230001598	MAX;CDH1;PRKCB;ZBTB16;EP300;STK4;JAK2
Chemokine signaling pathway	4/192	2.1142899366159956E-4	0.012154901046561148	0	0	15.587864460204885	131.89860661161714	PRKCB;PRKCD;ARRB1;JAK2
Fc gamma R-mediated phagocytosis	3/97	4.5042912506562216E-4	0.012154901046561148	0	0	22.65387537993921	174.55512838852647	PRKCB;PRKCD;ACTR3B
Chemical carcinogenesis	4/239	4.8552935355587566E-4	0.012154901046561148	0	0	12.440661938534278	94.92561966652285	VDR;PRKCB;ARRB1;JAK2
AGE-RAGE signaling pathway in diabetic complications	3/100	4.924436798304106E-4	0.012154901046561148	0	0	21.949926362297496	167.17350275311443	PRKCB;PRKCD;JAK2
Parathyroid hormone synthesis, secretion and action	3/106	5.83841527304732E-4	0.012154901046561148	0	0	20.66504854368932	153.86949168142752	VDR;PRKCB;ARRB1
Insulin resistance	3/108	6.165529516371596E-4	0.012154901046561148	0	0	20.26938775510204	149.81847055400618	PRKAB2;PRKCB;PRKCD
Growth hormone synthesis, secretion and action	3/119	8.174676820608766E-4	0.014101317515550122	0	0	18.33713054187192	130.36414728297743	PRKCB;EP300;JAK2
MAPK signaling pathway	4/294	0.0010526773665169523	0.014896536522649294	0	0	10.053128991060026	68.9284594700132	MAX;PRKCB;ARRB1;STK4
FoxO signaling pathway	3/131	0.0010794591683079197	0.014896536522649294	0	0	16.607979910714285	113.45401233897793	PRKAB2;EP300;STK4
Apelin signaling pathway	3/137	0.0012281995754051841	0.01540832194599231	0	0	15.85954157782516	106.2939137967113	HDAC5;PRKAB2;CDH1
Signaling pathways regulating pluripotency of stem cells	3/143	0.0013892920921965216	0.015976859060259998	0	0	15.175255102040817	99.83741068861235	KAT6A;JARID2;JAK2
Hepatitis B	3/162	0.0019851043893972984	0.02097460410593923	0	0	13.349056603773585	83.0589485340456	PRKCB;EP300;JAK2
Wnt signaling pathway	3/166	0.0021278583875590524	0.02097460410593923	0	0	13.018843120070114	80.10024526018454	TLE4;PRKCB;EP300
Influenza A	3/172	0.0023537337211029337	0.02165435023414699	0	0	12.552831783601015	75.96662980002893	PRKCB;EP300;JAK2
Tuberculosis	3/180	0.002677315818224289	0.023091848932184494	0	0	11.980629539951574	70.96055647741261	VDR;EP300;JAK2
Endocrine and other factor-regulated calcium reabsorption	2/53	0.003050060586094204	0.023330548556565966	0	0	26.934415145368494	156.02012683130314	VDR;PRKCB
Neutrophil extracellular trap formation	3/189	0.003072790945414164	0.023330548556565966	0	0	11.39573732718894	65.92626663221358	HDAC5;PRKCB;PADI4
Transcriptional misregulation in cancer	3/192	0.003212176975179372	0.023330548556565966	0	0	11.213151927437641	64.37253419547274	KMT2A;MAX;ZBTB16
Notch signaling pathway	2/59	0.00376531025589527	0.025980640765677365	0	0	24.091954022988507	134.47948084141416	TLE4;EP300
GnRH secretion	2/64	0.004415214615800143	0.029014267475258083	0	0	22.14349276974416	120.07749245655843	PRKCB;ARRB1
Long-term potentiation	2/67	0.004828328046458851	0.03028678501869643	0	0	21.118302387267903	112.62929246148852	PRKCB;EP300
Adipocytokine signaling pathway	2/69	0.005113293237096843	0.030663369683383762	0	0	20.485846628924342	108.08151613676682	PRKAB2;JAK2
Adherens junction	2/71	0.0054058487402184816	0.030663369683383762	0	0	19.89005497251374	103.83153308233095	CDH1;EP300
Non-small cell lung cancer	2/72	0.0055549582759753195	0.030663369683383762	0	0	19.604926108374386	101.8096431909553	PRKCB;STK4
Bacterial invasion of epithelial cells	2/77	0.006328591715250412	0.0323461354335021	0	0	18.293333333333333	92.61324789757649	CDH1;ACTR3B
Leishmaniasis	2/77	0.006328591715250412	0.0323461354335021	0	0	18.293333333333333	92.61324789757649	PRKCB;JAK2
Morphine addiction	2/91	0.008738708384625295	0.04306934846708181	0	0	15.404881828748547	73.0190302211722	PRKCB;ARRB1
GnRH signaling pathway	2/93	0.009111722662175992	0.043359231978630584	0	0	15.064797271693823	70.77733246775645	PRKCB;PRKCD
Inflammatory mediator regulation of TRP channels	2/98	0.010074977542143497	0.046344896693860084	0	0	14.276580459770114	65.6394396936512	PRKCB;PRKCD
Melanogenesis	2/101	0.010673774444413626	0.047515512042873555	0	0	13.841866945315221	62.841598838595445	PRKCB;EP300
Glucagon signaling pathway	2/107	0.011917578268540506	0.05010906798775486	0	0	13.046962233169129	57.79466096438427	PRKAB2;EP300
MicroRNAs in cancer	3/310	0.012027823320641578	0.05010906798775486	0	0	6.8620288506281995	30.333822942920527	HDAC5;PRKCB;EP300
HIF-1 signaling pathway	2/109	0.012345712402780182	0.05010906798775486	0	0	12.801804705124074	56.256845240677414	PRKCB;EP300
Cholinergic synapse	2/113	0.01322202189727877	0.05213254348069916	0	0	12.337993165579373	53.37257317425967	PRKCB;JAK2
Thyroid hormone signaling pathway	2/121	0.015053614496342767	0.05770552223598061	0	0	11.503911909591423	48.271992142820785	PRKCB;EP300
Dopaminergic synapse	2/132	0.017739783250801607	0.06534446592393013	0	0	10.524668435013263	42.43488974899699	PRKCB;ARRB1
Vascular smooth muscle contraction	2/133	0.017993403660212643	0.06534446592393013	0	0	10.443801000263226	41.96058200741095	PRKCB;PRKCD
Oxytocin signaling pathway	2/154	0.023669361800099178	0.0837531263695817	0	0	8.991379310344827	33.65989217584881	PRKAB2;PRKCB
JAK-STAT signaling pathway	2/162	0.02600161132240305	0.08970555906229052	0	0	8.538362068965517	31.161578618956735	EP300;JAK2
Tight junction	2/169	0.02811620438553538	0.09463502939521665	0	0	8.177575882717324	29.205469743912474	PRKAB2;ACTR3B
Kaposi sarcoma-associated herpesvirus infection	2/193	0.0358670030910624	0.11784872444206218	0	0	7.141361256544503	23.766004213100285	EP300;JAK2
Viral carcinogenesis	2/203	0.03931473917544402	0.12330531832298351	0	0	6.782638531480528	21.94967494010879	HDAC5;EP300
Diabetic cardiomyopathy	2/203	0.03931473917544402	0.12330531832298351	0	0	6.782638531480528	21.94967494010879	PRKCB;PRKCD
Rap1 signaling pathway	2/210	0.041800922935683583	0.1275660626126896	0	0	6.552055702917772	20.801707953702945	CDH1;PRKCB
Human immunodeficiency virus 1 infection	2/212	0.042522020870896536	0.1275660626126896	0	0	6.488998357963875	20.49052554384947	APOBEC3C;PRKCB
Circadian rhythm	1/31	0.04698359743176254	0.1379518392677283	0	0	22.154444444444444	67.74733246608147	PRKAB2
Thermogenesis	2/232	0.049986989677904846	0.14077968521532386	0	0	5.918740629685157	17.732502617988906	KDM3A;PRKAB2
Ras signaling pathway	2/232	0.049986989677904846	0.14077968521532386	0	0	5.918740629685157	17.732502617988906	PRKCB;STK4
Shigellosis	2/246	0.05547540811203006	0.145361157105224	0	0	5.575183719615602	16.12240243652396	PRKCD;ACTR3B
African trypanosomiasis	1/37	0.05582711106215124	0.145361157105224	0	0	18.456481481481482	53.25609732919314	PRKCB
Aldosterone-regulated sodium reabsorption	1/37	0.05582711106215124	0.145361157105224	0	0	18.456481481481482	53.25609732919314	PRKCB
Thyroid cancer	1/37	0.05582711106215124	0.145361157105224	0	0	18.456481481481482	53.25609732919314	CDH1
Endocytosis	2/252	0.057890639275392446	0.1479427448148918	0	0	5.439724137931035	15.49885971833384	ARRB1;ACTR3B
Bladder cancer	1/41	0.0616786118590254	0.15199372208116974	0	0	16.6075	46.2654733568564	CDH1
Homologous recombination	1/41	0.0616786118590254	0.15199372208116974	0	0	16.6075	46.2654733568564	UIMC1
Type II diabetes mellitus	1/46	0.06894365075528797	0.1669162070917498	0	0	14.75851851851852	39.471152501452366	PRKCD
Carbohydrate digestion and absorption	1/47	0.07039011205855722	0.16747992179449822	0	0	14.43695652173913	38.311387316676615	PRKCB
Hedgehog signaling pathway	1/56	0.0833107775481581	0.1948624966380647	0	0	12.069090909090908	29.993831432939842	ARRB1
Endometrial cancer	1/58	0.08615834477824497	0.19494657840982527	0	0	11.644444444444444	28.547152703267713	CDH1
VEGF signaling pathway	1/59	0.08757891647548653	0.19494657840982527	0	0	11.443103448275862	27.86641704377016	PRKCB
Long-term depression	1/60	0.0889973510131811	0.19494657840982527	0	0	11.248587570621469	27.21200570122755	PRKCB
Mineral absorption	1/60	0.0889973510131811	0.19494657840982527	0	0	11.248587570621469	27.21200570122755	VDR
Lysine degradation	1/63	0.09323986288089035	0.2010484543369198	0	0	10.702688172043011	25.39298321204175	KMT2A
Acute myeloid leukemia	1/67	0.09886681344336717	0.20916098940417088	0	0	10.052020202020202	23.26019032662989	ZBTB16
Amphetamine addiction	1/69	0.10166760200422945	0.20916098940417088	0	0	9.755392156862746	22.301280984489107	PRKCB
Renal cell carcinoma	1/69	0.10166760200422945	0.20916098940417088	0	0	9.755392156862746	22.301280984489107	EP300
Prolactin signaling pathway	1/70	0.10306483535857697	0.20916098940417088	0	0	9.61352657004831	21.8457491225909	JAK2
Melanoma	1/72	0.1058529955609793	0.2117059911219586	0	0	9.341784037558686	20.978881609749415	CDH1
Thyroid hormone synthesis	1/75	0.1100195153566116	0.21352466947292936	0	0	8.961711711711711	19.77937166333769	PRKCB
Glioma	1/75	0.1100195153566116	0.21352466947292936	0	0	8.961711711711711	19.77937166333769	PRKCB
Gastric acid secretion	1/76	0.11140417537718053	0.21352466947292936	0	0	8.841777777777779	19.40408125999615	PRKCB
B cell receptor signaling pathway	1/81	0.11829626253520985	0.22160006463058302	0	0	8.287083333333333	17.689302303265983	PRKCB
ErbB signaling pathway	1/85	0.123772658199863	0.22160006463058302	0	0	7.890873015873016	16.486470413825213	PRKCB
Insulin secretion	1/86	0.12513660526532908	0.22160006463058302	0	0	7.79764705882353	16.206234277302418	PRKCB
Gap junction	1/88	0.12785833813457156	0.22160006463058302	0	0	7.617624521072797	15.668176630929226	PRKCB
GABAergic synapse	1/89	0.1292161299361437	0.22160006463058302	0	0	7.530681818181818	15.409799629222077	PRKCB
PD-L1 expression and PD-1 checkpoint pathway in cancer	1/89	0.1292161299361437	0.22160006463058302	0	0	7.530681818181818	15.409799629222077	JAK2
Hypertrophic cardiomyopathy	1/90	0.13057187592621022	0.22160006463058302	0	0	7.4456928838951315	15.158175594574578	PRKAB2
Small cell lung cancer	1/92	0.13327724252917478	0.22160006463058302	0	0	7.281318681318681	14.674214761648551	MAX
Th1 and Th2 cell differentiation	1/92	0.13327724252917478	0.22160006463058302	0	0	7.281318681318681	14.674214761648551	JAK2
Salivary secretion	1/93	0.13462686905744525	0.22160006463058302	0	0	7.201811594202899	14.441420169325145	PRKCB
TGF-beta signaling pathway	1/94	0.1359744617032879	0.22160006463058302	0	0	7.124014336917563	14.21446168945804	EP300
Circadian entrainment	1/97	0.14000506588878114	0.22160006463058302	0	0	6.900347222222222	13.566611703053766	PRKCB
Phosphatidylinositol signaling system	1/97	0.14000506588878114	0.22160006463058302	0	0	6.900347222222222	13.566611703053766	PRKCB
Prostate cancer	1/97	0.14000506588878114	0.22160006463058302	0	0	6.900347222222222	13.566611703053766	EP300
Aldosterone synthesis and secretion	1/98	0.14134455256627768	0.22160006463058302	0	0	6.828865979381443	13.361050061201011	PRKCB
Choline metabolism in cancer	1/98	0.14134455256627768	0.22160006463058302	0	0	6.828865979381443	13.361050061201011	PRKCB
Amoebiasis	1/102	0.14668233749516316	0.22160006463058302	0	0	6.557095709570957	12.586253414445132	PRKCB
Longevity regulating pathway	1/102	0.14668233749516316	0.22160006463058302	0	0	6.557095709570957	12.586253414445132	PRKAB2
Pancreatic secretion	1/102	0.14668233749516316	0.22160006463058302	0	0	6.557095709570957	12.586253414445132	PRKCB
C-type lectin receptor signaling pathway	1/104	0.14933917399017552	0.22160006463058302	0	0	6.429126213592233	12.225209957636702	PRKCD
NF-kappa B signaling pathway	1/104	0.14933917399017552	0.22160006463058302	0	0	6.429126213592233	12.225209957636702	PRKCB
Th17 cell differentiation	1/107	0.1533094245816639	0.22507128289648531	0	0	6.246226415094339	11.713529763522214	JAK2
Toxoplasmosis	1/112	0.15988669182841242	0.228831783613158	0	0	5.963363363363364	10.932573768600097	JAK2
Serotonergic synapse	1/113	0.1611961988204034	0.228831783613158	0	0	5.909821428571429	10.786210288951333	PRKCB
Glutamatergic synapse	1/114	0.1625037303919528	0.228831783613158	0	0	5.857227138643068	10.642899882624762	PRKCB
Leukocyte transendothelial migration	1/114	0.1625037303919528	0.228831783613158	0	0	5.857227138643068	10.642899882624762	PRKCB
Sphingolipid signaling pathway	1/119	0.16901185764040969	0.23269750885036303	0	0	5.607627118644068	9.969163244438311	PRKCB
Neurotrophin signaling pathway	1/119	0.16901185764040969	0.23269750885036303	0	0	5.607627118644068	9.969163244438311	PRKCD
AMPK signaling pathway	1/120	0.17030759705714973	0.23269750885036303	0	0	5.560224089635854	9.842425570542433	PRKAB2
Cell cycle	1/124	0.1754710298811658	0.23740198160393022	0	0	5.378319783197832	9.359789460313923	EP300
Relaxin signaling pathway	1/129	0.18188160313378351	0.24368603138312744	0	0	5.166927083333333	8.806507089090594	ARRB1
Natural killer cell mediated cytotoxicity	1/131	0.18443230402669894	0.24472748034311972	0	0	5.086923076923077	8.599305090496161	PRKCB
Autophagy	1/137	0.19203831602803864	0.2453822927024938	0	0	4.861029411764706	8.020991961652324	PRKCD
Yersinia infection	1/137	0.19203831602803864	0.2453822927024938	0	0	4.861029411764706	8.020991961652324	ACTR3B
Estrogen signaling pathway	1/137	0.19203831602803864	0.2453822927024938	0	0	4.861029411764706	8.020991961652324	PRKCD
Insulin signaling pathway	1/137	0.19203831602803864	0.2453822927024938	0	0	4.861029411764706	8.020991961652324	PRKAB2
Spinocerebellar ataxia	1/143	0.19957566165973847	0.25267377347746706	0	0	4.654225352112676	7.500572056522554	PRKCB
Cell adhesion molecules	1/148	0.20580476208856874	0.25510894426716335	0	0	4.494784580498866	7.105478246409346	CDH1
Retrograde endocannabinoid signaling	1/148	0.20580476208856874	0.25510894426716335	0	0	4.494784580498866	7.105478246409346	PRKCB
Gastric cancer	1/149	0.20704494027479925	0.25510894426716335	0	0	4.464189189189189	7.030291769437623	CDH1
mTOR signaling pathway	1/154	0.21321777250448626	0.2573360955624746	0	0	4.317211328976035	6.6719963840461745	PRKCB
Cushing syndrome	1/155	0.21444674630206217	0.2573360955624746	0	0	4.288961038961039	6.603686893515271	KMT2A
Non-alcoholic fatty liver disease	1/155	0.21444674630206217	0.2573360955624746	0	0	4.288961038961039	6.603686893515271	PRKAB2
Necroptosis	1/159	0.2193440901375634	0.26094383137054955	0	0	4.179535864978903	6.340830678820871	JAK2
Hippo signaling pathway	1/163	0.22421188154749758	0.2644550397739715	0	0	4.075514403292181	6.093561498022166	CDH1
Hepatocellular carcinoma	1/168	0.23025532535380872	0.2692816516849627	0	0	3.9524950099800398	5.804501666402634	PRKCB
NOD-like receptor signaling pathway	1/181	0.24575583230160786	0.28499415846741083	0	0	3.6646296296296295	5.14300274246623	PRKCD
Alcoholism	1/186	0.251636767276824	0.28938228236834757	0	0	3.5646846846846847	4.918440107268859	HDAC5
Pathogenic Escherichia coli infection	1/197	0.2644190399487812	0.301568822420924	0	0	3.362755102040816	4.4732046355544925	ACTR3B
Focal adhesion	1/201	0.2690145471023502	0.304295143443642	0	0	3.2948333333333335	4.326082633154742	PRKCB
Proteoglycans in cancer	1/205	0.27358226454773577	0.30694595534624014	0	0	3.229575163398693	4.186023271598047	PRKCB
Lipid and atherosclerosis	1/215	0.2848810421449348	0.31441481998219273	0	0	3.0771028037383177	3.8638674702576408	JAK2
cAMP signaling pathway	1/216	0.28600151999716633	0.31441481998219273	0	0	3.0626356589147288	3.833679157249421	EP300
Regulation of actin cytoskeleton	1/218	0.28823738097399043	0.31441481998219273	0	0	3.0341013824884793	3.774333823982291	ACTR3B
Human T-cell leukemia virus 1 infection	1/219	0.2893527691140469	0.31441481998219273	0	0	3.020030581039755	3.745166140096708	EP300
Human cytomegalovirus infection	1/225	0.2960096607667956	0.3191354155142015	0	0	2.9382440476190474	3.5769101393596303	PRKCB
Coronavirus disease	1/232	0.3036997777963908	0.3248881343868366	0	0	2.848196248196248	3.3942400107364574	PRKCB
Calcium signaling pathway	1/240	0.3123889526255053	0.33161288817169027	0	0	2.7517433751743376	3.2016705453971914	PRKCB
Salmonella infection	1/249	0.3220388546682572	0.33924703774213355	0	0	2.650672043010753	3.0034316267817784	ACTR3B
Prion disease	1/273	0.34713557846868615	0.362914468399081	0	0	2.4138480392156865	2.5539474397756936	PRKCD
Huntington disease	1/306	0.38018022475896907	0.3944727144115619	0	0	2.1490710382513663	2.078387797409282	EP300
Human papillomavirus infection	1/331	0.40413049336693263	0.416194090183856	0	0	1.9837373737373738	1.797300676410323	EP300
PI3K-Akt signaling pathway	1/354	0.42537198022543804	0.4348246908971144	0	0	1.8523135033050047	1.5833413661284401	JAK2
Olfactory transduction	1/440	0.4984921747726414	0.5058229420487096	0	0	1.4829157175398633	1.0323575605928883	ARRB1
Pathways of neurodegeneration	1/475	0.5255972482043884	0.529433724468654	0	0	1.370956399437412	0.8818266401711002	PRKCB
Herpes simplex virus 1 infection	1/498	0.5426313163607573	0.5426313163607573	0	0	1.3059691482226694	0.7983718050886579	JAK2
